Shiga Toxin‐Mediated Retrograde Delivery of a Topoisomerase I Inhibitor Prodrug
- 20 August 2007
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition in English
- Vol. 46 (34) , 6469-6472
- https://doi.org/10.1002/anie.200701270
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Trafficking of Shiga toxin/Shiga-like toxin-1 in human glomerular microvascular endothelial cells and human mesangial cellsKidney International, 2006
- The Endoplasmic Reticulum: Folding, Calcium Homeostasis, Signaling, and Redox ControlAntioxidants and Redox Signaling, 2006
- In vivo Tumor Targeting Using a Novel Intestinal Pathogen-Based Delivery ApproachCancer Research, 2006
- The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancerProceedings of the National Academy of Sciences, 2005
- Protein toxins: intracellular trafficking for targeted therapyGene Therapy, 2005
- Delivery into cells: lessons learned from plant and bacterial toxinsGene Therapy, 2005
- Ligand-targeted therapeutics in anticancer therapyNature Reviews Cancer, 2002
- Targeting of Shiga Toxin B-Subunit to Retrograde Transport Route in Association with Detergent-resistant MembranesMolecular Biology of the Cell, 2001
- Drug targetingEuropean Journal of Pharmaceutical Sciences, 2000
- Shiga Toxin: Biochemistry, Genetics, Mode of Action, and Role in PathogenesisPublished by Springer Nature ,1992